Highlights a live single circulating tumor cell (sCTC) capture assay for contamination-free cancer cell isolation.
Demonstrates multi-omics profiling using isolated circulating tumor cells for genomic and molecular analysis.
Showcases mutation detection and analytical validation for precision oncology applications.
Presents liquid biopsy capabilities for identifying tumor biomarkers across multiple cancer types.
Features single-cell genomic profiling to support cancer research and personalized treatment strategies.
Includes comparative analysis between sCTCs and ctDNA for improved cancer diagnostics.
Emphasizes the role of AI-powered precision oncology in advancing tumor heterogeneity assessment.
Illustrates a novel platform for non-invasive cancer monitoring, biomarker discovery, and targeted therapy insights.